IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S: Financial statements 2015
CVR: 16584037
Source: annual report 2015, Danish Business Authority
01/04/2014 – 31/03/2015
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S (CVR 16584037) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 8,955,998 and a net result of DKK 5,980,943 compared with DKK 9,192,971 the year before. That is a decrease of 33.1% compared with the year before. Equity in the 2015 report amounted to DKK 84,703,323. The solvency ratio was 97.9%.
- Gross Profit
- DKK 8,955,998
- Profit/Loss
- DKK 5,980,943
- Equity
- DKK 84,703,323
- Total Assets
- DKK 86,505,873
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 9M | 6M | 84.7M | - |
| 2014 | - | 13.4M | 9.2M | 78.7M | - |
| 2013 | - | 11.7M | 7.1M | 69.5M | - |
Official annual report
How creditworthy is IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 10, 2015, Nicola Mitton has joined the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of September 10, 2015, Christopher Henry Francis Yates has left the board of directors of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 26, 2015, Carlos Patricio Lacalle Zando is registered as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of March 26, 2015, Patrik Olof Dahlén has stepped down as chairman of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
About IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S was a Danish company of the type Aktieselskab based in København S, founded in 1992. The company has been dissolved on 11 October 2019. The company was registered under the industry Engroshandel med kemiske produkter. The company was previously named NORDIC BIOSCIENCE DIAGNOSTICS A/S and OSTEOMETER BIOTECH A/S. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 877,018 and a net result of DKK 1,209,814 compared with DKK 5,073,540 the year before. Equity in the 2019 report amounted to DKK 102,384,800.
